SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Mueller T.) "

Search: WFRF:(Mueller T.)

  • Result 1-10 of 1132
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Belov, Vladimir, et al. (author)
  • Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures
  • 2024
  • In: Scientific Reports. - : NATURE PORTFOLIO. - 2045-2322. ; 14:1
  • Journal article (peer-reviewed)abstract
    • Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to date (N = 5365) to provide a generalizable ML classification benchmark of major depressive disorder (MDD) using shallow linear and non-linear models. Leveraging brain measures from standardized ENIGMA analysis pipelines in FreeSurfer, we were able to classify MDD versus healthy controls (HC) with a balanced accuracy of around 62%. But after harmonizing the data, e.g., using ComBat, the balanced accuracy dropped to approximately 52%. Accuracy results close to random chance levels were also observed in stratified groups according to age of onset, antidepressant use, number of episodes and sex. Future studies incorporating higher dimensional brain imaging/phenotype features, and/or using more advanced machine and deep learning methods may yield more encouraging prospects.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Frieler, Katja, et al. (author)
  • Scenario setup and forcing data for impact model evaluation and impact attribution within the third round of the Inter-Sectoral Impact Model Intercomparison Project (ISIMIP3a)
  • 2024
  • In: Geoscientific Model Development. - : Copernicus Publications. - 1991-959X .- 1991-9603. ; 17:1, s. 1-51
  • Journal article (peer-reviewed)abstract
    • This paper describes the rationale and the protocol of the first component of the third simulation round of the Inter-Sectoral Impact Model Intercomparison Project (ISIMIP3a, http://www.isimip.org, last access: 2 November 2023) and the associated set of climate-related and direct human forcing data (CRF and DHF, respectively). The observation-based climate-related forcings for the first time include high-resolution observational climate forcings derived by orographic downscaling, monthly to hourly coastal water levels, and wind fields associated with historical tropical cyclones. The DHFs include land use patterns, population densities, information about water and agricultural management, and fishing intensities. The ISIMIP3a impact model simulations driven by these observation-based climate-related and direct human forcings are designed to test to what degree the impact models can explain observed changes in natural and human systems. In a second set of ISIMIP3a experiments the participating impact models are forced by the same DHFs but a counterfactual set of atmospheric forcings and coastal water levels where observed trends have been removed. These experiments are designed to allow for the attribution of observed changes in natural, human, and managed systems to climate change, rising CH4 and CO2 concentrations, and sea level rise according to the definition of the Working Group II contribution to the IPCC AR6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • O'Regan, Ruth M., et al. (author)
  • Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer
  • 2024
  • In: JAMA ONCOLOGY. - 2374-2437 .- 2374-2445.
  • Journal article (peer-reviewed)abstract
    • Importance Adjuvant ovarian function suppression (OFS) with oral endocrine therapy improves outcomes for premenopausal patients with hormone receptor-positive (HR+) breast cancer but adds adverse effects. A genomic biomarker for selecting patients most likely to benefit from OFS-based treatment is lacking. Objective To assess the predictive and prognostic performance of the Breast Cancer Index (BCI) for OFS benefit in premenopausal women with HR+ breast cancer. Design, Setting, and Participants This prospective-retrospective translational study used all available tumor tissue samples from female patients from the Suppression of Ovarian Function Trial (SOFT). These individuals were randomized to receive 5 years of adjuvant tamoxifen alone, tamoxifen plus OFS, or exemestane plus OFS. BCI testing was performed blinded to clinical data and outcome. The a priori hypothesis was that BCI HOXB13/IL17BR ratio (BCI[H/I])-high tumors would benefit more from OFS and high BCI portended poorer prognosis in this population. Settings spanned multiple centers internationally. Participants included premenopausal female patients with HR+ early breast cancer with specimens in the International Breast Cancer Study Group tumor repository available for RNA extraction. Data were collected from December 2003 to April 2021 and were analyzed from May 2022 to October 2022. Main Outcomes and Measures Primary end points were breast cancer-free interval (BCFI) for the predictive analysis and distant recurrence-free interval (DRFI) for the prognostic analyses. Results Tumor specimens were available for 1718 of the 3047 female patients in the SOFT intention-to-treat population. The 1687 patients (98.2%) who had specimens that yielded sufficient RNA for BCI testing represented the parent trial population. The median (IQR) follow-up time was 12 (10.5-13.4) years, and 512 patients (30.3%) were younger than 40 years. Tumors were BCI(H/I)-low for 972 patients (57.6%) and BCI(H/I)-high for 715 patients (42.4%). Patients with tumors classified as BCI(H/I)-low exhibited a 12-year absolute benefit in BCFI of 11.6% from exemestane plus OFS (hazard ratio [HR], 0.48 [95% CI, 0.33-0.71]) and an absolute benefit of 7.3% from tamoxifen plus OFS (HR, 0.69 [95% CI, 0.48-0.97]) relative to tamoxifen alone. In contrast, patients with BCI(H/I)-high tumors did not benefit from either exemestane plus OFS (absolute benefit, -0.4%; HR, 1.03 [95% CI, 0.70-1.53]; P for interaction = .006) or tamoxifen plus OFS (absolute benefit, -1.2%; HR, 1.05 [95% CI, 0.72-1.54]; P for interaction = .11) compared with tamoxifen alone. BCI continuous index was significantly prognostic in the N0 subgroup for DRFI (n = 1110; P = .004), with 12-year DRFI of 95.9%, 90.8%, and 86.3% in BCI low-risk, intermediate-risk, and high-risk N0 cancers, respectively. Conclusions and Relevance In this prospective-retrospective translational study of patients enrolled in SOFT, BCI was confirmed as prognostic in premenopausal women with HR+ breast cancer. The benefit from OFS-containing adjuvant endocrine therapy was greater for patients with BCI(H/I)-low tumors than BCI(H/I)-high tumors. BCI(H/I)-low status may identify premenopausal patients who are likely to benefit from this more intensive endocrine therapy.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 1132
Type of publication
journal article (948)
conference paper (34)
research review (17)
reports (2)
Type of content
peer-reviewed (1081)
other academic/artistic (39)
pop. science, debate, etc. (1)
Author/Editor
Yang, H. (573)
Eigen, G. (546)
Salt, J. (546)
Elsing, M. (545)
Ferrer, A. (545)
Fuster, J. (545)
show more...
Hamacher, K. (545)
Liebig, W. (545)
Stugu, B. (545)
Vrba, V. (545)
Fassouliotis, D. (544)
Garcia, C. (544)
Masik, J. (544)
Nicolaidou, R. (544)
Ouraou, A. (544)
Benekos, N. (543)
Besson, N. (543)
Kourkoumelis, C. (543)
Leitner, R. (543)
Weiser, C. (543)
Boonekamp, M. (542)
Haug, S. (542)
Lipniacka, A. (542)
Maltezos, S. (541)
Canale, V. (540)
Di Ciaccio, L. (540)
Chudoba, J. (539)
Parzefall, U. (539)
Andreazza, A. (538)
Graziani, E. (538)
van Vulpen, I. (538)
Abdallah, J (537)
Di Simone, A. (535)
Meroni, C. (535)
Anjos, N. (534)
Onofre, A. (534)
Troncon, C. (534)
Parodi, F. (533)
Baroncelli, A. (529)
Kluit, P. (529)
Meyer, J. (528)
Veloso, F. (528)
Klein, M. (527)
Mehta, A. (527)
Sankey, D. P. C. (527)
Brandt, G. (526)
Glazov, A. (526)
Lee, S. C. (526)
Landon, M. P. J. (525)
Rizvi, E. (525)
show less...
University
Lund University (654)
Uppsala University (459)
Stockholm University (390)
Royal Institute of Technology (330)
Karolinska Institutet (186)
University of Gothenburg (72)
show more...
Chalmers University of Technology (45)
Umeå University (36)
Högskolan Dalarna (36)
Linköping University (14)
Mid Sweden University (12)
Swedish University of Agricultural Sciences (7)
Luleå University of Technology (6)
Örebro University (6)
Södertörn University (4)
Jönköping University (2)
Linnaeus University (2)
Karlstad University (2)
Stockholm School of Economics (1)
RISE (1)
IVL Swedish Environmental Research Institute (1)
show less...
Language
English (1132)
Research subject (UKÄ/SCB)
Natural sciences (717)
Medical and Health Sciences (150)
Social Sciences (12)
Engineering and Technology (11)
Agricultural Sciences (4)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view